Two new apotirucallane triterpenoids, namely chisiamols G (1) and H (2), featuring a 21,23-lactone, together with five known triterpenoids, were isolated from the twigs of Chisocheton paniculatus. The structures of the new compounds were elucidated on the basis of spectroscopic and chemical methods.
Introduction
The genus Chisocheton (Meliaceae) comprising about 50 species is mainly distributed in India and Malaysia, which is traditionally used to treat stomach and kidney problems, backache, fever, rheumatism and malaria. Chisocheton paniculatus is the only species growing in southern China. 1 Phytochemical studies of genus Chisocheton have led to the isolation of sesquiterpenoids, triterpenoids and limonoids, some of which showed anti-inflammatory, anti-feedant, anti-fungal and cytotoxic activities. Previous phytochemical investigation on C. paniculatus resulted mainly in the isolation of apotirucallane-type triterpenoids. 2 In the present study, two new apotirucallane triterpenoids, named chisiamols G (1) and H (2), together with five known triterpenoids, chisiamol A (3), 2m sapelin B (4), 3 3-acetoxy-21,24R-epoxyapotirucall-14ene-7,23R,25-triol (5) , 2m chisiamol B (6) , 2m and 3-acetoxy-21,23-epoxyapotirucall-14-ene-7,21R,24,25-tetrol (7) 2m were isolated from the leaves and stems of C. paniculatus (Figure 1) . Herein, we describe the isolation and structural elucidation of these new compounds.
Results and Discussion
Compound 1 was obtained as a white amorphous powder. Its molecular formula was determined to be C 32 (Table 1) . Careful analysis of its 1 H and 13 C NMR data indicated that the NMR data of 1 highly resembled those of the coexisting compound 3-acetoxy-21,23-epoxyapotirucall-14ene-7,21R,24,25-tetrol (7) 2m except for the absence of both the proton and carbon signals of the hemiacetal group ( C 96.5;  H 5.29), and the presence of an additional ester carbonyl, suggesting that C-21 hemiacetal in 7 was oxygenated to a lactone group ( C 181.6) in 1. To prove this speculation, an HMBC experiment was performed, in which, the ester carbonyl was placed at C-21 by the correlations from H 2 -22 ( H 2.18-2.33) and H-20 ( H 2.81-2.90) to C-21 ( C 181.6). This was supported by 1 H-1 H COSY spectrum, in which, a proton bearing structural fragment from C-17 to C-24 as depicted in bold bond ( Figure 2 ) was revealed. In addition, the key HMBC correlations from H-3 ( H 4.63) to C-1′ ( C 173.2) assigned an acetoxy group at C-3; the HMBC correlations of Me-30 ( H 1.12)/C-7 ( C 74.4), and H-7 ( H 3.95)/C-6 located a hydroxyl group at C-7 ( Figure 2 ). In the ROESY spectrum of 1, the correlations of Me-19/H-3, Me-29/H-3, Me-19/Me-30, and Me-30/H-7, indicated that Me-19, Me-29, Me-30, H-3, and H-7 were cofacial and were randomly assigned to be -oriented. Subsequently, the ROESY correlations of H-20/H-23, and Me-18/H-20 indicated that they were -oriented ( Figure 4 ). The small coupling constant (1.9 Hz) between H-23 and H-24 indicated that they were in a gauche relationship, showing that H-24 was oriented. 4 The structure of compound 1 was further verified by chemical correlation with the coexisting known compound 7. Both compounds 1 and 7 were treated with LiAlH 4 to afford a common compound 8 (Figure 3 ), 5 confirming the structural assignment for compound 1. The structure of 8 was assigned as the reduced derivative of compound 7 based on the spectroscopic data. In the ESIMS, the [M  Na] + peak at m/z 531.4, [2M  Na] + peak at m/z 1039. Hence, the structure of 1, namely chisiamol G, was assigned as 3-acetoxy-7,24,25-trihydroxyl-21,23-epoxyapotirucall-14-ene-21-one, an apotirucallane-type triterpenoid possessing a five-membered lactone formed between C-21 and C-23.
Compound 2 was obtained as a white amorphous powder. Its molecular formula C 32 H 48 O 6 was assigned by HRESIMS at m/z [M  Na] + 551.3348 (calcd for C 32 H 48 O 6 Na, 551.3349). Its IR spectrum exhibited absorption bands for hydroxyl (3432 cm -1 ), ester carbonyl (1724 cm -1 ), and double bond (1630 cm -1 ) functionalities. A comparison of the 13 C NMR spectra (Table 1) of compounds 1 and 2 revealed that their structures were close related, except for that two oxygenated carbon signals at  C 79.5 (C-24) and at  C 73.9 (C-25) in 1 were significantly upfield shifted to  C 66.4 (C-24) and  C 59.4 (C-25) in 2, respectively, suggesting that an 24,25-epoxide ring was present in 2 instead of the 24,25-diol motif in 1. This was consistent with the fact that the molecular weight of 2 was 18 mass units less than that of 1, and was further supported by the almost identical chemical shifts of C-24 and C-25 of 2 as compared with those of 7-hydroxyl-21-acetoxy-21,23epoxyapotirucall-24,25-epoxide-14-ene-3-one and 3,7-dihydroxyl-21-acetoxy-21,23-epoxyapotirucall-24,25-epoxide-14-ene, both of which possessing an 24,25-epoxide were respectively reported as compounds A and D in the literature. 2a The structure of 2 was finally confirmed by 2D NMR spectra, especially HMBC ( Figure 2 ) and ROESY (Figure 4 (Figure 4 ). 6 The chemical shifts of C-24 ( C 66.4) and C-25 ( C 59.4), and the coupling constant (J 23,24 = 8.1 Hz) between H-23 and H-24 further supported the -orientation of the epoxide in 2 as compared with the corresponding data of the bruceajavanones AE. 6 The structure of 2 was thus established as 3-acetoxy-7-hydroxyl-21,23-epoxyapotirucall-24,25-epoxide-14-ene-21one, namely chisiamol H.
All isolated compounds (17) were tested in an antimicrobial assay against Helicobacter pylori-SS1 in vitro according to standard protocols, in which Minimum inhibitory concentration (MIC) > 100 g/mL was defined as inactive 7 , and metronidazole (Shanghai Henshan Pharmaceutical Company, Ltd. with a purity of 99%; MIC = 0.312 g/mL) was used as the positive control. However, none of these compounds showed activity (MIC > 50 g/mL).
Experimental Section
General Experimental Procedures. Optical rotations were measured with a Perkin-Elmer 341 polarimeter. UV spectra were measured on a Shimadzu UV-2550 spectrophotometer. IR spectra were recorded on a Perkin-Elmer 577 spectrometer using KBr disks. NMR spectra were measured on a Bruker AM-400 spectrometer. ESIMS was carried out on a Finnigan LCQ-DECA instrument, and HRESIMS spectra were made on a Bruker Daltonics micrOTOFQII or a Waters-Micromass Q-TOF Ultima Global electrospray mass spectrometer. All solvents used were of analytical grade (Shanghai Chemical Reagents Company, Ltd.). Different absorbents were employed for column chromatography: silica gel (200300 mesh) and silica gel H (Qingdao Haiyang Chemical Co. Ltd.); RP-18 reversed silica gel (150200 mesh, Merck); MCI gel (CHP20P, 75150 ím, Mitsubishi Chemical Industries Ltd.); Sephadex LH-20 gel (Amersham Biosciences). Fractions were monitored by TLC (silica gel GF254, 0.25 mm, Merck), and spots were visualized by heating silica gel plates sprayed with 10% H 2 SO 4 in ethanol. Semipreparative HPLC was performed on a Waters 1525 pump equipped with a Waters 2489 detector Extraction and Isolation. Dried leaves and stems of C. paniculatus (6 kg) were extracted by 95% EtOH at room temperature. The crude extract (70 g) was dissolved in H 2 O (500 mL) and then extracted with EtOAc (200 mL × 3). The EtOAc extract (24 g) was subjected to an MCI column (75150 m, 8  30 cm, MeOH/H 2 O, 50:50 to 90:10, v/v) to give fractions EK. Fraction I (1.80 g) was chromatographed on a silica gel column eluted with petroleum ether/Me 2 CO (300400 mesh, 4  20 cm, 10:1 to 4:1) to yield four fractions (I14). Fraction I4 (193 mg) was subjected to a silica gel column (300400 mesh, 3  18 cm, CH 2 Cl 2 /MeOH, 150:1, 100:1, 70:1, 50:1, 30:1, 20:1, 10:1) to give four fractions (I4ad). Purification of fraction I4b (30 mg) by a RP-18 silica gel column (150200 mesh, 3  15 cm, MeOH/H 2 O, 70:30 to 80:20) gave 1 (20 mg). Fraction J (5.50 g) was chromatographed on a silica gel column eluted with petroleum ether/Me 2 CO (300400 mesh, 8  20 cm, 10:1 to 6:1) to yield seven fractions (J17). Fraction J3 (221 mg) was submitted to a silica gel column (300400 mesh, 3  20 cm, CH 2 Cl 2 /MeOH, 100:1, 80:1, 60:1) to give three fractions (J3ac). Purification of fraction J3a (12 mg) with Sephadex LH-20 (3  100 cm, EtOH) yielded 2 (3 mg) . Fraction J3b (73 mg) was applied to a RP-18 silica gel column (150200 mesh, 3  15 cm, MeOH/H 2 O, 80:20 to 90:10) to give fractions J3b1 and J3b2. Fraction J3b2 (14 mg) was further purified by preparative HPLC (eluting with MeCN/H 2 O, 85:15 to 95:5, from 0 to 20 min, 3 mL/min) afforded 3 (3 mg) . Purification of fraction J3c (15 mg) by preparative HPLC (eluting with MeCN/H 2 O, 90:10 to 95:5, from 0 to 20 min, 3 mL/min) yielded 4 (4 mg). Fraction J5 (358 mg) and J6 (293 mg) were subjected to a silica gel column (300400 mesh, 3  20 cm, petroleum ether/ EtOAc, 10:1, 8:1, 6:1, 4:1) to give two corresponding fractions J5ab and J6ab, respectively. Fraction J5a (140 mg) and J6a (255 mg) were applied to a silica gel column (300400 mesh, 3  18 cm, CH 2 Cl 2 /MeOH, 100:1, 80:1, 60:1, 40:1) to give three corresponding fractions J5a13 and J6a13, respectively. Purification of fractions J5a2 (40 mg) and J6a3 (83 mg) were subjected to RP-18 silica gel column (150200 mesh, 3  15 cm, MeOH/H 2 O, 90:10 to 100:0) to afford 5 (35 mg) and 6 (9 mg). Fraction E (1.34 g) was chromatographed on a silica gel column eluted with petroleum ether/Me 2 CO (300400 mesh, 6  20 cm, 10:1 to 1:1) to yield seven fractions (E17). Purification of fraction E3 (40 mg) was applied to RP-18 silica gel column (150200 mesh, 3  15 cm, MeOH/H 2 O, 80:20 to 90:10) to afford 7 (20 mg). 3448, 2939, 2871, 1765, 1720, 1630, 1458, 1385, 1169, 1034 3432, 2937, 2871, 1774, 1724, 1630, 1458, 1385, 1250, 1188, 1024, 818 Reduction of Compounds 1 and 7 with LiAlH 4 . To a cooled solution (-78 °C) of compound 1 or 7 (5.0 mg) in dry THF (2 mL), LiAlH 4 (3 mg) was added under nitrogen atmosphere. After stirring at the same temperature for 2 h, the reaction mixture was then allowed to r.t. and kept stirring overnight. After workup, the reaction mixture was diluted with H 2 O (2 mL) and then extracted with EtOAc (3  5 mL). The combined organic phase were dried with anhydrous Na 2 SO 4 and concentrated in vacuo to obtain the crude product, which was purified by a silica gel column eluted with CH 2 Cl 2 /MeOH (300400 mesh, 3  12 cm, 50:1 to 10:1) to give compound 8 (about 3.0 mg). 
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